Therapeutic innovation for multi-resistant candidemics: synergy of isavuconazole and caspofungin association
Fungal infections occurring in immunocompromised patients after immuno-chemotherapy treatment, are often difficult to eradicate and capable of even being fatal. Systemic mycoses affecting severely immunocompromised patients often manifest acutely with rapidly progressive pneumonia, fungemia, or mani...
Main Authors: | Andrea Duminuco, Elisa Mauro, Giuseppe A. M. Palumbo, Bruno Garibaldi, Marina Parisi, Francesco Di Raimondo, Cinzia Maugeri, Calogero Vetro |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-11-01
|
Series: | Hematology Reports |
Subjects: | |
Online Access: | https://www.pagepress.org/journals/index.php/hr/article/view/9329 |
Similar Items
-
Isavuconazole—Animal Data and Clinical Data
by: Livio Pagano, et al.
Published: (2020-10-01) -
Peripheral Candidal Suppurative Thrombophlebitis Successfully Treated with Caspofungin in a Bariatric Surgery Patient
by: Özgür GÜNAL, et al.
Published: (2012-12-01) -
Epidemiology and Antifungal Susceptibility of Candida Species Isolated from 10 Tertiary Care Hospitals in Iran
by: Parisa Badiee, et al.
Published: (2022-12-01) -
Synergistic In Vitro Interaction of Isavuconazole and Isoquercitrin against <i>Candida glabrata</i>
by: Petra V. Schwarz, et al.
Published: (2022-05-01) -
Isavuconazole Treatment for Invasive Fungal Infections in Pediatric Patients
by: Philippe Zimmermann, et al.
Published: (2022-03-01)